Marston's 16-week Like-for-like Sales Rise About 13%

Marston's Plc (MARS.L), a British pub and hotel operator, said on Tuesday that it has posted a rise in like-for-like sales for the 16-week period to January 21, amidst a firm demand, especially during festive and New Year season.

For the 16-week period, the retailer's like-for-like sales grew by 12.9 percent from the same period of 2022.

For the five key festive days, including Christmas Eve, Christmas Day, Boxing Day, New Year's Eve and New Year's Day, like-for-like sales grew 26 percent from the same period of previous fiscal.

Total retail sales in the Group's managed and franchised pubs were up 14 percent on last year as the drink sales continued to outperform food sales.

Looking ahead, Andrew Andrea, CEO, said: "…Whilst we still have certain cost challenges to navigate in 2023, we are well-positioned to continue to progress our strategy and are encouraged by the level of consumer resilience experienced to date."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Boeing has delivered its final 747 jumbo jet, bringing to a close more than 50 years of its production, to Atlas Air Worldwide, the largest operator of the widebody jet called as the "Queen of the Skies." The aerospace and defense major and Atlas Air joined thousands of people to celebrate the delivery of the final 747-8 Freighter at the Everett factory, where 747 began its journey in 1967. Branded food company Conagra Brands Inc. has recalled about 2.58 million pounds of canned meat and poultry products citing a packaging defect, the U.S. Department of Agriculture's Food Safety and Inspection Service sad in a statement. According to the agency, the possible packaging defect may cause the products to become contaminated without showing any outward signs of contamination. Drug major Pfizer Inc. reported Tuesday higher earnings in its fourth quarter, above market estimates, and an all-time high revenues in its fiscal 2022. Meanwhile, the company projects sharply lower adjusted earnings and revenues in its fiscal 2023, below Wall Street estimates, reflecting projected decline for COVID-19 products. In pre-market activity on the NYSE, Pfizer shares were losing around
Follow RTT